Klaus Vander
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 detection and testing 2
-
- Influenza Virus Research Studies 2
- Co-authors
- Kristijan Skok (3 shared papers)Michael Trauner (3 shared papers)Sigurd Lax (3 shared papers)Harald H. Kessler (6 shared papers)Peter Zechner (2 shared papers)Patrick Sadoghi (1 shared paper)Andreas Leithner (1 shared paper)Lukas Leitner (1 shared paper)
In The Last Decade
Klaus Vander
8 papers receiving 593 citations
Klaus Vander's Hit Papers
Peers
Comparison fields: 5 of 54
- Internal Medicine 83
- Infectious Diseases 376
- Neurology 177
- Oncology 110
- Critical Care and Intensive Care Medicine 18
Countries citing papers authored by Klaus Vander
This map shows the geographic impact of Klaus Vander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Vander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Vander more than expected).
Fields of papers citing papers by Klaus Vander
This network shows the impact of papers produced by Klaus Vander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Vander. The network helps show where Klaus Vander may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus Vander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome Hit paper breakdown → | 2020 | 508 |
| 2 | 2018 | 55 | |
| 3 | 2020 | 13 | |
| 4 | 2020 | 13 | |
| 5 | 2013 | 6 | |
| 6 | 2015 | 6 | |
| 7 | 2013 | 1 | |
| 8 | 2022 | 1 |
About Klaus Vander
Klaus Vander is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Dermatology and General Dentistry, having authored 8 papers that have together received 603 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 detection and testing (2 papers), Influenza Virus Research Studies (2 papers), Dermatological and COVID-19 studies (1 paper), Infection Control and Ventilation (1 paper), Biosensors and Analytical Detection (1 paper), Dental Research and COVID-19 (1 paper) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Internal Medicine (83 citations), Infectious Diseases (376 citations), Neurology (177 citations), Oncology (110 citations) and Critical Care and Intensive Care Medicine (18 citations). Klaus Vander has collaborated with scholars based in Austria, Czechia and Germany. Frequent co-authors include Kristijan Skok, Michael Trauner, Sigurd Lax, Harald H. Kessler, Peter Zechner, Patrick Sadoghi, Andreas Leithner, Lukas Leitner, Roman Radl and Florian Amerstorfer. Their work appears in journals such as Clinical Microbiology and Infection, European Spine Journal, Infection, Annals of Internal Medicine and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.